JAZZ vs TXMD · P/E 1988, rev $4.07B vs rev $1.8M
Jazz Pharmaceuticals PLC (JAZZ) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the JAZZ and TXMD stock pages for the full models.
Not investment advice.